Background/Aims: Exposure to diabetes in utero has been established as a significantrisk factor for some of components of metabolic syndrome. A few studies have examined relationship between the metabolic syndrome and echocardiographic left ventricular (LV) mass. We aimed to investigate relationship between abdominal aortic intima-media thickness (aIMT), LV mass and lipid profile in macrosomic newborns. Methods: Abdominal aIMT was measured in 30 macrosomic neonates of diabetic mothers (group A), 30 macrosomic neonates of healthy mothers (group B) and 30 healthy neonates (group C). Lipid profile and LV mass were determined. Result: Mean aIMT was significantly higher in groups A and B (0.489 ± 0.015, 0.466 ± 0.019 mm, respectively) than in controls (0.375 ± 0.024 mm). Weight-adjusted aIMT in group A was significantly higher than in groups B and C. Macrosomia was associated with increased lipid concentrations. Both LV mass indexed for BSA (body surface area) and birth weight measurements were significantly increased in group A compared with control. Conclusions: Macrosomic neonates of diabetic mothers have significant aIMT and LV mass indexed for BSA and birth weight with lipid alterations. It might play a role in the pathogenesis of atherosclerosis in adult life.

1.
Lepercq J, Taupin P, Dubois-Laforgue D, Duranteau L, Lahlou N, Boitard C, Landais P, Hauguel-De Mouzon S, Timsit J: Heterogeneity of fetal growth in type I diabetic pregnancy. Diabetes Metab 20001;27:339–344.
2.
Mountain K: The infant of the diabetic mother (review). Baillieres Clin Obstet Gynecol 1991;5:413–442.
3.
Barbara J, Stoll and Robert MK: The Endocrine System; in Behrman RE, Kliegman MR, Jenson HB (eds): Nelson Textbook of Pediatrics, ed 17. Philadelphia, Saunders, 2004.
4.
Eidelman AI, Samueloff A: The pathophysiology of the fetus of the diabetic mother. Semin Perinatol 2002;26:232–236.
5.
Chernicky CL, Redline RW, Tan HQ, Gwatkin RB, Johnson TR, Ilan J, Ilan J: Expression of insulin-like growth factors I and II in conceptuses from normal and diabetic mice. Mol Reprod Dev 1994;37:382–390.
6.
Lombardi G, Colao A, Marzullo P, Ferone D, Longobardi S, Esposito V: Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly. J Endocrinol 1997;155:33–37.
7.
Barker DJ: Fetal origins of coronary heart disease. BMJ 1995;311:171–174.
8.
Merzouk H, Madani S, Prost J, Loukidi B, Meghelli-Bouchenak M, Belleville J: Changes in serum lipid and lipoprotein concentrations and compositions at birth and after 1 month of life in macrosomic infants of insulin-dependent diabetic mothers. Eur J Pediatr 1999;158:750–756.
9.
Charles M, Pettitt D, Hanson R, Bennett PH, Saad MF, Liu QZ, Knowler WC: Familial and metabolic factors related to blood pressure in Pima Indian children. Am J Epidemiol 1994;140:123–131.
10.
Burchfiel CM, Skelton TN, Andrew ME, Garrison RJ, Arnett DK, Jones DW, Taylor HA Jr: Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2005;112:819–827.
11.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561–1566.
12.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989;110:101–107.
13.
Gordon T, Kannel WB: Premature mortality from coronary heart disease: the Framingham Study. JAMA 1971;21:1617–1625.
14.
Jarvisalo MJ, Jartti L, Nanto-Salonen K, Irjala K, Ronnemaa T, Hartiala JJ, Celermajer DS, Raitakari OT: Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001;104:2943–2947.
15.
Kimble K, Darnell RA, Yelderman M, Ariagno RL, Ream AK: An automated oscillometric technique for estimating mean arterial pressure in critically ill newborns. Anesthesiology 1981;54:423–425.
16.
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
17.
Schifreen RS, Hichkingbotham JM: Accuracy, precision and stability in measurement of HbA 1c by performance cation exchange chromatography. Clinical Chem 1980;26:466–470.
18.
McGill HC Jr, McMahan CA, Herderick EE, Tracy RE, Malcom GT, Zieske AW, Strong JP: Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol 2000;20:836–845.
19.
Sahn D, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: results of survey of echocardiographic measurements. Circulation 1978;58:1072–1083.
20.
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reicheck N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450–458.
21.
Bland JM, Altman DG: Applying the right statistics: analyses of measurements studies. Ultrasound Obstet Gynecol 2003;22:85–93.
22.
Rosenn B, Tsang RC: The effects of maternal diabetes on the fetus and the neonate. Ann Clin Lab Sci 1991;21:153–168.
23.
Hill DE: Effect of insulin on fetal growth. Semin Perinatol 1978;2:319–328.
24.
Kalkhoff RK, Kandaraki E, Morrow PG, Mitchell TH, Kelber S, Borkowf HI: Relationship between neonatal birth weight and maternal plasma amino acid profiles in lean and obese nondiabetic women and in type 1 diabetic pregnant woman. Metabolism 1988;37:234–239.
25.
Bayes-Genis A, Conover CA, Schwartz RS: The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res 2000;86:125–130.
26.
Ruotolo G, Bavenholm P, Brismar K, Efendic S, Ericsson CG, de Faire U, Nilsson J, Hamsten A: Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. J Am Coll Cardiol 2000;35:647–654.
27.
Colao A, Spiezia S, Cerbone G, Pivonello R, Marzullo P, Ferone D, Di Somma C, Assanti AP, Lombardi G: Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin Endocrinol (Oxf) 2001;54:515–524.
28.
Brevetti G, Marzullo P, Silvestro A, Pivonello R, Oliva G, di Somma C, Lombardi G, Colao A: Early vascular alterations in acromegaly. J Clin Endocrinol Metab 2002;87:3174–3179.
29.
Raitakari OT: Imaging of subclinical atherosclerosis in children and young adults. Ann Med 1999;31:33–40.
30.
Tonstad S, Joakimsen O, Stensland-Bugge E, Leren TP, Ose L, Russell D, Bonaa KH: Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol 1996;16:984–991.
31.
Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ: Weight in infancy and death from ischaemic heart disease. Lancet 1989;2:577–580.
32.
Mi J, Law C, Zhang KL, Osmond C, Stein C, Barker D: Effects of infant birth weight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern Med 2000;132:253–260.
33.
Molina M, Casanueva V, Cid X, Ferrada MC, Perez R, Dios G, Reyes M, Venegas H, Cid L: Lipid profile in newborns with intrauterine growth retardation. Rev Med Chil 2000;128:741–748.
34.
Skilton MR, Evans N, Griffiths KA, Harmer JA, Celermajer DS: Aortic wall thickness in newborns with intrauterine growth restriction. Lancet 2005;365:1484–1486.
35.
Koklu E, Kurtoglu S, Akcakus M, Koklu S, Buyukkayhan D, Gumus H, Yikilmaz A: Increased aortic intima-media thickness is related to lipid profile in newborns with intrauterine growth restriction. Horm Res 2006;65:269–275.
36.
Way GL, Wolfe RR, Eshaghpour E, Bender RL, Jaffe RB, Ruttenberg HD: The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers. J Pediatr 1979;95:1020–1025.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.